Effects of Pregnancy and Intensity of Plasmodium falciparum Transmission on Immunoglobulin G Subclass Responses to Variant Surface Antigens
Open Access
- 1 July 2005
- journal article
- Published by American Society for Microbiology in Infection and Immunity
- Vol. 73 (7) , 4112-4118
- https://doi.org/10.1128/iai.73.7.4112-4118.2005
Abstract
Placenta-sequestering Plasmodium falciparum involved in the pathogenesis of pregnancy-associated malaria (PAM) in otherwise clinically immune women expresses particular variant surface antigens (VSA PAM ) on the surface of infected erythrocytes that differ from VSA found in parasitized nonpregnant individuals (non-PAM type VSA). We studied levels of immunoglobulin G (IgG) and IgG subclasses with specificity for VSA PAM and for non-PAM type VSA in pregnant and nonpregnant women from two sites with different endemicities in Cameroon. We found that VSA PAM -specific responses depended on the pregnancy status, parity, gestational age, and parasite transmission intensity, whereas only the parasite transmission intensity influenced the levels of IgG specific for non-PAM type VSA. For both types of VSA, the responses were dominated by the cytophilic subclass IgG1, followed by IgG3. In pregnant women, the levels of VSA PAM -specific antibodies either were very low or negative or were very high, whereas the levels of the antibodies specific for non-PAM type VSA were uniformly high. Interestingly, the levels of VSA PAM -specific IgG1 increased with increasing gestational age, while the levels of the corresponding IgG3 tended to decrease with increasing gestational age. The IgG subclass responses with specificity for non-PAM type VSA did not vary significantly with gestational age. Taken together, our data indicate that IgG1 and to a lesser extent IgG3 are the main subclasses involved in acquired VSA PAM -specific immunity to pregnancy-associated malaria.Keywords
This publication has 32 references indexed in Scilit:
- Pregnancy-associated Malaria and the Prospects for Syndrome-specific Antimalaria VaccinesThe Journal of Experimental Medicine, 2004
- Geographical and Temporal Conservation of Antibody Recognition of Plasmodium falciparum Variant Surface AntigensInfection and Immunity, 2004
- Antibodies That Inhibit Binding of Plasmodium falciparum -Infected Erythrocytes to Chondroitin Sulfate A and to the C Terminus of Merozoite Surface Protein 1 Correlate with Reduced Placental Malaria in Cameroonian WomenInfection and Immunity, 2004
- Antibodies That Inhibit Plasmodium falciparum Adhesion to Chondroitin Sulfate A Are Associated with Increased Birth Weight and the Gestational Age of NewbornsInfection and Immunity, 2003
- Expression of Variant Surface Antigens by Plasmodium falciparum Parasites in the Peripheral Blood of Clinically Immune Pregnant Women Indicates Ongoing Placental InfectionInfection and Immunity, 2003
- Gravidity-Dependent Production of Antibodies That Inhibit Binding ofPlasmodium falciparum-Infected Erythrocytes to Placental Chondroitin Sulfate Proteoglycan during PregnancyInfection and Immunity, 2001
- Acquisition and Decay of Antibodies to Pregnancy‐Associated Variant Antigens on the Surface ofPlasmodium falciparum–Infected Erythrocytes That Protect against Placental ParasitemiaThe Journal of Infectious Diseases, 2001
- Immune response to Plasmodium falciparum antigens in Cameroonian primigravidae: evolution after delivery and during second pregnancyClinical and Experimental Immunology, 1997
- Chondroitin sulfate A is a cell surface receptor for Plasmodium falciparum-infected erythrocytes.The Journal of Experimental Medicine, 1995
- Antigens Induced on Erythrocytes by P. falciparum : Expression of Diverse and Conserved DeterminantsScience, 1986